Platinum Sponsor
Gold Sponsors
|
Confirmed Capstone
Dr. Ronald A. Paulus
Executive Vice President, Chief Technology and Innovation Officer, Geisinger Health System
Ronald A. Paulus, MD, MBA, is Executive Vice President and Chief Technology and Innovation Officer, responsible for ensuring system-wide innovation at Geisinger Health System. At Geisinger, Dr. Paulus provides leadership, oversight and direction for:
- Clinical Innovation including work on:
- ProvenCare®, Geisinger’s episode-based care model with a “90 day warranty”;
- Personal Health NavigatorSM, Geisinger’s patient-centered medical home model;
- Transitions of Care, Geisinger’s model to ensure safe, reliable and seamless transitions across care settings;
- EHR (Epic) analytic and workflow optimization;
- Clinical Decision Intelligence System, Geisinger’s enterprise-wide data warehouse and analytic environment; and
- Geisinger Ventures, Geisinger’s for-profit new business formation and technology transfer organization.
Immediately prior to joining Geisinger, he was Chief Healthcare Officer for Quovadx, Inc. (previously NASDAQ: QVDX), responsible for healthcare strategy for this software and services company with more than 450 employees and 10,000 customers worldwide. Prior to its acquisition by Quovadx in September 2003, Dr. Paulus was co-founder, President and CEO of CareScience, Inc. (previously NASDAQ: CARE), where he had also served as President and Chief Operating Officer. CareScience, now part of Premier healthcare informatics, is a clinical solutions and data analytics provider which aims to improve the quality and efficiency of healthcare and to support drug and product development for life sciences companies.
Before joining CareScience, Dr. Paulus served as Vice President, Operations of Salick Health Care, Inc. (previously NASDAQ: SHCI), a national provider of ambulatory services to individuals with high-risk, chronic diseases primarily focused on oncology and dialysis patients. Salick Health Care was a NASDAQ company acquired by AstraZeneca Pharmaceuticals. While at Salick Health Care, he also served as Managing Director of its INFUSX subsidiary, a provider of alternate site therapies to patients with high risk, chronic diseases.
Dr. Paulus received his MD degree from The School of Medicine, University of Pennsylvania, and his MBA, concentration in healthcare management, and BS in Economics from The Wharton School, University of Pennsylvania. Dr. Paulus has served on numerous national panels and advisory boards including: the Healthcare Information Technology Advisory Board for the Joint Commission on Accreditation of Healthcare Organizations (JCAHO), the Inpatient Functionality and Interoperability Workgroups for the Certifying Commission on Healthcare Information Technology (CCHIT), the eHealth Initiative Leadership Council, the Information Technology Workgroup of the Academic Medicine and Managed Care Forum, the Data Standards Workgroup of the National Quality Forum Institute of Medicine Summit on Information Technology, the IBM Healthcare and Lifesciences Advisory Council and the University of Pennsylvania School of Medicine Alumni Leadership Council. He teaches in the Wharton Healthcare MBA Program and speaks nationally on innovation, new care model design, clinical transformation, EHR optimization, data analytics and pay-for-performance.
Topic of His Talk - A Prescription for Change: What Real "Health Reform" Would Look Like.
Dr. Paulus will discuss several Geisinger Innovation experiments and their potential
implications for real "health reform." Unlike efforts that tinker with the margin like most pay-for-performance initiatives or the current magical thinking in Washington that "HIT pixie dust" will solve all problems, Dr. Paulus will address the need for fundamental changes in incentives, operations and care delivery models that can produce dramatic improvements in quality and efficiency.
|
